Another study found higher rates of discrimination among older blacks receiving health treatment for chronic conditions than whites. » Read More
A start-up called Luna DNA wants to fuse two big trends: cryptocurrency and DNA. » Read More
By: Gleb Tsipursky, assistant professor at Ohio State University
If the CDC is unable to make accurate recommendations, the consequences could be dire, says Ohio State professor Gleb Tsipursky. » Read More
By: Christina Farr
"I always say that there are two places where we can measure everything," said biosensor expert Steven LeBoeuf. "The ear and the rear." » Read More
Barry Sherman, who founded generic drugmaker Apotex in 1974, and his wife, Honey, were found dead in their Toronto home on Friday.
The FDA plans to take a more aggressive role in regulating homeopathic drugs that are potentially harmful and unproven.
U.S. health insurer Humana is in advanced talks to acquire acute care provider Kindred Healthcare in partnership with private equity firms.
The world awakens to Myanmar-Rohingya crisis, but finding a solution is easier said than done.
A Social Security cost-of-living increase and Medicare could change your benefits in 2018.
The final bill would let itemizers deduct medical expenses in 2017 and 2018 that exceed 7.5 percent of their adjusted gross income.
Jim Cramer highlighted his one big fear going in to 2018.
Centene's unit had admitted having inadequate networks of covered doctors for its Obamacare plans in Washington.
Lower unecessary ambulance usage can translate both to lower wait times for for ambulances, and lower bills to patients.
Venture capitalists and start-ups are betting they can play a crucial role in helping fix one of the country's most vexing problems.
Fitbit won't be profitable and will continue to burn through cash next year, Stifel writes, downgrading it to a sell rating.
Wait times at HealthCare.gov's call center were 30 minutes or more Friday morning, an unusually long wait for that time.
Goldman Sachs raises its rating to buy for the generic drugmaker, citing Teva's aggressive cost-cutting targets for the next two years.
Siemens' businesses will become akin to a "fleet of ships" in order to adapt to the digital age, its chief executive told CNBC on Friday.
Demand has been strong for Obamacare plans, but because of an earlier deadline this year, enrollment nationally is expected to drop.
Famed short seller Jim Chaos told CNBC that he believes "winter is coming" for health care stocks.
Get the best of CNBC in your inbox